Old Web
English
Sign In
Acemap
>
Paper
>
1.22 Comparative Assessment of Two Kinase Inhibitors, Sorafenib and Dasatinib, on CLL Cells
1.22 Comparative Assessment of Two Kinase Inhibitors, Sorafenib and Dasatinib, on CLL Cells
2011
Mirjam Kuckertz
Michaela Patz
Aditya Veldurthy
Michael Hallek
Günter Krause
Keywords:
Immunology
Kinase
Sorafenib
Medicine
Dasatinib
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]